Antimalarial drugs clear resistant parasites from partially immune hosts.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.PLoS neglected tropical diseases · 2010
   Pooled it
2. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast.PloS one · 2011
   Trial
3. Intermittent Preventive Treatment (IPT): Its Role in Averting Disease-Induced Mortality in Children and in Promoting the Spread of Antimalarial Drug Resistance.Bulletin of mathematical biology · 2019
   Article
4. Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.Antimicrobial agents and chemotherapy · 2016
   Article
5. Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies.Antimicrobial agents and chemotherapy · 2016
   Article
6. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
   Article
7. Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso.Malaria journal · 2012
   Article
8. Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2012
   Article
9. Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites.Malaria journal · 2011
   Article
10. High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria.Acta tropica · 2011
    Article
11. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
12. Plasmodium falciparum: differential selection of drug resistance alleles in contiguous urban and peri-urban areas of Brazzaville, Republic of Congo.PloS one · 2011
    Article
13. Evolutionary biology and the avoidance of antimicrobial resistance.Evolutionary applications · 2009
    Article
14. Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as